Englitazone administration to late pregnant rats produces delayed body growth and insulin resistance in their fetuses and neonates

Biochemical Journal

Volumn 389, Issue 3, 2005, Pages 913-918

  Sevillano, Julio ^a   López Pérez, Inmaculada C ^a   Herrera, Emilio ^a   Del Pilar Ramos, María ^a   Bocos, Carlos ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Englitazone; Insulin; Lipoprotein lipase (LPL); Peroxisome proliferator activated receptor (PPAR); Thiazolidinedione; Triacylglycerol

Indexed keywords

BIOLOGICAL ORGANS; CELLS; DRUG THERAPY; FATTY ACIDS; INSULIN; TISSUE;

ENGLITAZONE ADMINISTRATION; NEONATES; RATS; TRIACYLGLYCEROLS;

BIOCHEMICAL ENGINEERING;

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ENGLITAZONE; FATTY ACID; LIGAND; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; SOMATOMEDIN C; TRIACYLGLYCEROL;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FETUS; FETUS GROWTH; GROWTH INHIBITION; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; LIVER CELL; NEWBORN; NONHUMAN; PERINATAL DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTILIPEMIC AGENTS; BENZOPYRANS; BODY WEIGHT; FATTY ACIDS, NONESTERIFIED; FEMALE; FETAL DEVELOPMENT; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; KETONES; LIPOPROTEIN LIPASE; LIVER; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 23744515635     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20041837     Document Type: Article

References (50)

1. Bocos, C., Gottlicher, M., Gearing, K., Banner, C., Enmark, E., Teboul, M., Crickmore, A. and Gustafson, J.-Å. (1995) Fatty acid activation of peroxisome proliferator-activated receptor (PPAR). J. Steroid Biochem. Mol. Biol. 53, 467-473
2. Rumi, M. A. K., Sato, H., Ishihara, S., Kawashima, K., Hamamoto, S., Kazumori, H., Okuyama, T., Fukuda, R., Nagasue, N. and Kinoshita, Y. (2001) Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma. Br. J. Cancer 84, 1640-1647
3. Zilversmit, D. B. (1995) Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin. Chem. 41, 153-158
4. Watts, G. F. and Dimmitt, S. B. (1999) Fibrates, dyslipoproteinaemia and cardiovascular disease. Curr. Opin. Lipidol. 10, 561-574
5. Lefebvre, A. M., Peinado-Onsurbe, J., Leitersdorf, I., Briggs, M. R., Paterniti, J. R., Fruchart, J. C., Fievet, C., Auwerx, J. and Staels, B. (1997) Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates. Arterioscler. Thromb. Vasc. Biol. 17, 1756-1764
6. Stevenson, R. W., Hutson, N. J., Krupp, M. N., Volkmann, R. A., Holland, G. F., Eggler, J. F., Clark, D. A., McPherson, R. K., Hall, K. L., Danbury, B. H. et al. (1990) Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice. Diabetes 39, 1218-1227
7. Parulkar, A. A., Pendergrass, M. L., Granda-Ayala, R., Lee, T. R. and Fonseca, V. A. (2001) Nonhypoglycemic effects of thiazolidinediones. Ann. Intern. Med. 134, 61-71
8. Herrera, E. and Amusquivar, E. (2000) Lipid metabolism in the fetus and the newborn. Diabetes Metab. Res. Rev. 16, 202-210
9. Chaves, J. M. and Herrera, E. (1978) In vitro glycerol metabolism in adipose tissue from fasted pregnant rats. Biochem. Biophys. Res. Commun. 85, 1299-1306
10. Soria, A., Chicco, A., Mocchiutti, N., Gutman, R. A., Lombarde, Y. B., Martin-Hidalgo, A. and Herrera, E. (1996) A sucrose-rich diet affects triglyceride metabolism differently in pregnant and nonpregnant rats and has negative effects on fetal growth. J. Nutr. 126, 2481-2486
11. Martin-Hidalgo, A., Holm, C., Beifrage, P., Schotz, M. C. and Herrera, E. (1994) Lipoprotein lipase and hormone-sensitive lipase activity and mRNA in rat adipose tissue during pregnancy. Am. J. Physiol. 266, E930-E935
12. Henck, J. W., Craft, W. R., Black, A., Colgin, J. and Anderson, J. A. (1998) Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats. Fundam. Appl. Toxicol. 41, 88-99
13. Knopp, R. H., Bergelin, R. O., Wahl, P. W. and Walden, C. E. (1985) Relationships of infant birth size to maternal lipoproteins, apoproteins, fuels, hormones, clinical chemistries, and body weight at 36 weeks gestation. Diabetes 34, 71-77
14. Soria, A., Bocos, C. and Herrera, E. (2002) Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats. J. Lipid Res. 43, 74-81
15. Barham, D. and Trinder, P. (1972) An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 97, 142-145
16. Somogy, M. (1945) Determination of blood sugar. J. Biol. Chem. 160, 69-73
17. Williamson, D. H., Mellanby, T. and Krebs, H. A. (1962) Enzymatic determination of D(-)-β-hydroxybutyric acid and acetonic acid in blood. Biochem. J. 82, 90-96
18. Llobera, M., Montes, A. and Herrera, E. (1979) Lipoprotein lipase activity in liver of the rat fetus. Biochem. Biophys. Res. Commun. 91, 272-277
19. Bowen, L., Stein, P. P., Stevenson, R. and Shulman, G. I. (1991) The effect of CP 68, 722, a thiazolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats. Metab., Clin. Exp. 40, 1025-1030
20. Stevenson, R. W., McPherson, R. K., Genereux, P. E., Danbury, B. H. and Kreutter, D. K. (1991) Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia. Metab., Clin. Exp. 40, 1268-1274
21. O'Moore-Sullivan, T. M. and Prins, J. B. (2002) Thiazolidinediones and type 2 diabetes: new drugs for an old disease. Med. J. Aust. 176, 381-386
22. Schaefer-Graf, U. M., Kjos, S. L., Kilavuz, O., Plagemann, A., Brauer, M., Dudenhausen, J. W. and Vetter, K. (2003) Determinants of fetal growth at different periods of pregnancies complicated by gestational diabetes mellitus or impaired glucose tolerance. Diabetes Care 26, 193-198
23. Girard, J., Ferré, P., Gilvert, M., Kervran, A., Assan, R. and Marliss, E. (1977) Fetal metabolic response to maternal fasting in the rat. Am. J. Physiol. 232, E456-E463
24. Herrera, E., Palacín, M., Martín, M. and Lasunción, M. A. (1985) Relationship between maternal and fetal fuels and placental glucose transport in rats with maternal diabetes of varying severity. Diabetes 34, 42-46
25. Shelley, H. J. (1979) Transfer of carbohydrates. In Placental Transfer (Chamberlain, G. V. P. and Wilkinson, A. W., eds.), pp. 118-141, Pitman Medical, London
26. Lyonnet, S., Coupé, C., Girard, J., Kahn, A. and Munnich, A. (1988) In vivo regulation of glycolytic and gluconeogenic enzyme gene expression in newborn rat liver. J. Clin. Invest. 81, 1682-1689
27. Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J. and Reitman, M. L. (2003) Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body mass. J. Biol. Chem. 278, 34268-34276
28. Chao, L., Marcus-Samuels, B., Mason, M. M., Moitra, J., Vinson, C., Arioglu, E., Gavrilova, O. and Reitman, M. L. (2000) Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J. Clin. Invest. 106, 1221-1228
29. Valmaseda, A., Carmona, M. C., Barbera, M. J., Vinas, O., Mampel, T., Iglesias, R., Villarroya, F. and Giralt, M. (1999) Opposite regulation of PPAR-α and -γ gene expression by both their ligands and retinoic acid in brown adipocytes. Mol. Cell Endocrinol. 154, 101-109
30. Larsen, P. J., Jensen, P. B., Sorensen, R. V., Larsen, L. K., Vrang, N., Wulff, E. M. and Wassermann, K. (2003) Differential influences of peroxisome proliferator-activated receptors γ and -α on food intake and energy homeostasis. Diabetes 52, 2249-2259
31. Grinberg, D. R., Ramirez, I., Vilaró, S., Reina, M., Llobera, M. and Herrera, E. (1985) Starvation enhances lipoprotein lipase activity in the liver of the newborn rat. Biochim. Biophys. Acta 833, 217-222
32. Asins, G., Serra, D., Arias, G. and Hegardt, F. G. (1995) Developmental changes in carnitine palmitoyltransferases I and II gene expression in intestine and liver of suckling rats. Biochem. J. 306, 379-384
33. Morimoto, C., Tsujita, T. and Okuda, H. (1998) Antilipolytic actions of insulin on basal and hormone-induced lipolysis in rat adipocytes. J. Lipid Res. 39, 957-962
34. Ramirez, I., Llobera, M. and Herrera, E. (1983) Circulating triacylglycerols, lipoproteins, and tissue lipoprotein lipase activities in rat mothers and offspring during the perinatal period: effect of postmaturity. Metab., Clin. Exp. 32, 333-341
35. Tardif, A., Julien, N., Pelletier, A., Thibault, G., Srivastava, A. K., Chiasson, J.-L. and Coderre, L. (2001) Chronic exposure to β- hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes. Am. J. Physiol. Endocrinol. Metab. 281, E1205-E1212
36. Merkel, M., Weinstock, P. H., Chajek-Shaul, T., Radner, H., Yin, B., Breslow, J. L. and Goldberg, I. J. (1998) Lipoprotein lipase expression exclusively in liver. J. Clin. Invest. 102, 893-901
37. Dessolin, S., Schalling, M., Champigny, O., Lonnqvist, F., Ailhaud, G., Dani, C. and Ricquier, D. (1997) Leptin gene is expressed in rat brown adipose tissue at birth. FASEB J. 11, 382-387
38. Kallen, C. B. and Lazar, M. A. (1996) Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. U.S.A. 93, 5793-5796
39. Hoggard, N., Hunter, L., Duncan, J. S., Williams, L. M., Trayhurn, P. and Mercer, J. G. (1997) Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc. Natl. Acad. Sci. U.S.A. 94, 11073-11078
40. Di Cola, G., Cool, M. H. and Accili, D. (1997) Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J. Clin. Invest. 99, 2538-2544
41. Holt, R. I. G. (2002) Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol. Metab. 13, 392-397
42. Sjogren, K., Liu, J.-L., Blad, K., Skrtic, S., Vidai, O., Wallenius, V., LeRoith, D., Tornell, J., Isaksson, O. G., Jansson, J. O. and Ohlsson, C. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. U.S.A. 96, 7088-7092
43. Gluckman, P. D., Butler, J. H., Comline, R. and Fowden, A. (1987) The effects of pancreatectomy on the plasma concentrations of insulin-like growth factors 1 and 2 in the sheep fetus. J. Dev. Physiol. 9, 79-88
44. Stoll, B. A. (2002) Linkage between retinoid and fatty acid receptors: implications for breast cancer prevention. Eur. J. Cancer Prev. 11, 319-325
45. Rieusset, J., Seydoux, J., Anghel, S. I., Escher, P., Michalik, L., Soon Tan, N., Metzger, D., Chambon, P., Wahli, W. and Desvergne, B. (2004) Altered growth in male peroxisome proliferator-activated receptor γ (PPARγ) heterozygous mice: involvement of PPARγ in a negative feedback regulation of growth hormone action. Mol. Endocrinol. 18, 2363-2377
46. Egawa, K., Sharma, P. M., Nakashima, N., Huang, Y., Huver, E., Boss, G. R. and Olefsky, J. M. (1999) Membrane targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance. J. Biol. Chem. 274, 14306-14314
47. Jiang, G., Dallas-Yang, Q., Li, Z., Szalkowski, D., Liu, F., Shen, X., Wu, M., Zhou, G., Doebber, T., Berger, J. et al. (2002) Potentiation of insulin signalling in tissues of Zucker obese rats after acute and long-term treatment with PPARγ agonists. Diabetes 51, 2412-2419
48. Meyer, M. M., Levin, K., Grimmsmann, T., Perwitz, N., Eirich, A., Beck-Nielsen, H. and Klein, H. H. (2002) Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes. Diabetes 51, 2691-2697
49. Patel, L., Pass, I., Coxon, P., Downes, C. P., Smith, S. A. and Macphee, C. H. (2001) Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN. Curr. Biol. 11, 764-768
50. Di-Poï, N., Tan, N. S., Michalik, L., Wahli, W. and Desvergne, B. (2002) Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol. Cell 10, 721-733